On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Bloomberg Washington Correspondents Joe Mathieu and Kailey Leinz deliver insight and analysis on the latest headlines from ...

Cigna Group closed $14.69 short of its 52-week high ($370.83), which the company reached on September 16th.

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

Cigna Healthcare's divestiture of low-margin Medicare businesses will allow focus on employer-sponsored plans. Learn more on ...

Shares of Cigna Group CI slid 0.24% to $355.39 Wednesday, on what proved to be an all-around poor trading session for the ...

Cigna Group (CI) stock saw a decline, ending the day at $356.23 which represents a decrease of $-10.62 or -2.89% from the prior close of $366.85. The stock opened at $364.66 and touched a low of $354.

Cencora (COR) stock slips as Bank of America downgrades citing risks to its relationships with major customers Walgreens (WBA) and Cigna (CI). Read more here.